 | |||||
| lung cancer | |||||
| 新闻 | |||||
| BioNTech says dual-acting lung cancer drug helped shrink tumors | BioPharma Dive The Bristol Myers-partnered bispecific antibody kept small cell lung cancer under control in participants enrolled in a Phase 2 trial.
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
 以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment